Top Tech Companies (2,180)
We optimize your health with precision nourishment. All your nutrients, scientifically optimized to your body’s daily needs, are provided through a diverse variety of delicious entrees, made fresh, locally, & daily. Conveniently available or delivered for less than your average takeout. Enjoy precision nourishment every meal, every day.
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Genus is a world-leading animal genetics company. At the forefront of innovation in gene-editing, advanced reproductive biology, and other breakthrough breeding technologies, Genus R&D advances an agricultural practice thousands of years old – animal breeding. Our goal is to ensure the global food system continues to nurture healthy, productive animals that yield affordable, high-quality proteins for a sustainable future. We believe a more sustainable food system starts with better breeding and genetics. Through ABS Global (bovine) and PIC (porcine), we supply high-quality breeding animals with desirable characteristics to farmers, enabling them to produce better quality meat and milk more efficiently to feed the world more sustainably. Our breeding animals’ desirable characteristics include feed efficiency, disease resistance, growth rate, protein and fat content, and fertility. ABS Global is the world-leading provider of bovine genetics, reproduction services, technologies, and udder care products. Marketing in more than 70 countries around the globe, ABS has been at the forefront of animal genetics and technology since its founding in 1941. In bovine genetics, ABS serves more than 40,000 customers globally, including some of the world’s leading beef and dairy producers. PIC, which stands for ‘Pig Improvement Company,’ was founded in 1962 in Oxfordshire, England. PIC strives to make their customers the most successful pig producers in the world and their “Never Stop Improving” philosophy means a continuous effort to listen carefully to customers and drive innovation to create ever-increasing value for pig and pork producers
Blackrock Neurotech builds implantable brain technology that changes lives. Our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer’s, Parkinson’s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders.
Westlake Chemical (NYSE: WLK) is a quality manufacturer and dependable global supplier of petrochemicals, plastics and building products. Our mission is to serve our clients by enhancing daily life through the products and services we provide, which in turn make life better for people every day. Employing approximately 9,500 people, Westlake operates from 36 locations in North America, 11 in Europe and 6 in Asia.
CUSABIO is a National High-Tech Enterprise with research, production and sales in one.
NovoThelium is a biotechnology company developing a tissue-engineered nipple matrix for use in breast reconstruction.
DSI is a pioneering biomedical research company focused on systems physiology and pharmacology.
DermBiont’s mission is to become the world’s leading precision dermatology company developing and commercializing targeted topical therapeutics that treat, cure, and prevent diseases. The company aims to impact the root causes of skin diseases through the development of targeted small molecule therapeutics with well-defined mechanisms of action and biotherapeutics that repair an imbalance of the microbiome. The company’s targeted topical therapeutics pipeline includes SM-020 for the treatment of seborrheic keratosis, SM-030 for the treatment of hyperpigmentation disorders of the skin, and DBI-001 & DBI-002 for the treatment of atopic dermatitis, tinea pedis, and onychomycosis. For more information, please visit www.dermbiont.com.
First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD).
Medical devices for molecular diagnostics, we specialize in self or assisted sampling, and transport of biological samples
Over the past decade, Advanced Brain Monitoring has developed and implemented mobile, user-friendly platforms for acquiring, integrating, analyzing and reporting multi-sensor data in real-world applications. Our strong and growing technical team includes PhD- and masters-level hardware engineers, biostatisticians, software engineers and experts in signal processing, experimental design and clinical trials. ABM seeks to build on existing collaborations within the academic community and develop strategic partnerships across industry with like-minded professionals.
Digital Proteomics offers antibody sequencing and discovery services.
Apertura is a biotechnology company opening opportunities in gene therapy for treating debilitating diseases with limited options. We are pioneering next-generation AAV gene therapies by simultaneously engineering capsids, regulatory elements, and payloads to overcome current limitations in genetic medicine. Founded on technologies from the Broad Institute and Harvard University, and with support from Deerfield Management Company, we are located at the Cure in New York City.
Tenvie is a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases. The company’s foundation is purpose-built with a diverse portfolio of small molecules and a proven team of CNS drug developers to rapidly deliver multiple clinical assets. Tenvie is advancing a pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases. Its portfolio of wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function.
Ambit Consulting Services (ACS) is a rapidly-expanding team of professionals dedicated to helping our clients deliver innovative therapies to improve the lives of patients. ACS provides guidance on our clients’ biggest strategic challenges, including corporate, medical and digital strategy and organizational transformation. Our work is informed by our extensive collective experience, but we don’t rely on cookie-cutter templates. In keeping our eye on the big picture, we also don’t lose sight of the “on-the-ground” realities of strategy implementation. As such, we highly value intellectual curiosity among our team – a willingness to continually dig deeper to understand the “why” and “how” of addressing a client challenge. Our work is fast-paced but intellectually invigorating. We support our employees and their career growth, fostering a team of talented, collegial individuals who are continually striving to help our clients succeed.
ScitoVation provides clients with the science, technical expertise and technology to understand how chemical compounds and drugs affect human health. Known for partnership, flexibility and proven success, we help clients develop safer and more effective pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals, and consumer products. We are recognized as industry experts in cell-based and computational methods who answer profound questions and provide leading-edge solutions for our clients. ScitoVation is at the vanguard of our field, using experience, curiosity and energy to investigate complex issues, such as mode of action of a chemical, extrapolation of animal to human exposure, and the use of genetic expression and sequencing data to ascertain toxicity. Specifically, we have the innovative people and tools to: develop cutting edge customized cell-based assays to determine safety, model chemical disposition in the body, and analyze and interpret genetic data. ScitoVation is made up of accomplished leaders in chemical safety. Our scientists pioneered the field of PBPK modeling for understanding chemical disposition and have been recognized by their peers for their contributions.
For over 30 years, Miltenyi Biotec has been a major provider of products and services that drive biomedical research and boost cell and gene therapy. More than 3,500 employees in 28 countries combine excellence in research with innovative products to create cutting-edge solutions that make cancer and other disease history. Our expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. At Miltenyi Biotec, scientists, engineers, software developers and many other professionals work together to improve human health by providing smarter cellular technology solutions to researchers and clinicians worldwide.
Hexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics. Our proprietary platform combines data science, genomics, synthetic biology, chemistry and automation to discover potent, evolutionarily-refined small molecules and their cognate targets directly from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
We are a team of engineers, scientists and doctors working at the intersection of AI, Physics and Biology to make the Star Trek MedBay a reality.
